[Form 4] Dynatrace, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Dynatrace director Jill A. Ward reported movements in her equity awards on Form 4. The filing records the reclassification of 3,981 time-based restricted stock units (RSUs) from non-derivative to derivative treatment and shows those 3,981 RSUs vested in full on August 20, 2025, converting into shares of common stock. Following the reported transactions, the reporting person beneficially owned 40,611 shares of common stock.
The Form 4 also discloses a new grant of 4,111 RSUs that will vest on the earlier of August 20, 2026 or the 2026 annual meeting, subject to continued service. Each RSU represents a contingent right to receive one share and carries $0 exercise price until settlement.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director equity activity: vesting and a new time-based RSU grant, no unusual acceleration or sale.
The Form 4 documents a standard governance outcome where previously granted time-based RSUs vested upon the specified corporate event (the 2025 annual meeting), resulting in an increase in beneficially owned common shares. The filing also records a follow-on grant of RSUs with a one-year vesting horizon tied to service and the 2026 annual meeting. This pattern is consistent with typical director compensation practices and contains no indicators of unusual insider sales or change-in-control accelerations.
TL;DR: Equity compensation moves reflect scheduled vesting and a standard one-year service-contingent grant of 4,111 RSUs.
The 3,981 RSUs that vested on August 20, 2025 were originally granted on August 23, 2024 and were converted into common shares as disclosed. The newly granted 4,111 RSUs vest on the earlier of one year after grant or the 2026 annual meeting, subject to continued board service. The RSUs are zero-priced contingent awards that do not expire but are forfeited if vesting conditions are not met. These disclosures are material to director dilution and insider ownership calculations but are routine in nature.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 3,981 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 4,111 | $0.00 | -- |
| Exercise | Common Stock | 3,981 | $0.00 | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- This Form 4 reports the moving of unvested time-based restricted stock units ("RSUs") previously reported in Table I to Table II in addition to the transactions reflected herein. Reflects a decrease of 3,981 shares of the Issuer's Common Stock representing unvested RSUs that were previously reported in Table I and are being reported in Table II of this Form 4 as derivative securities. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. As previously reported on August 27, 2024, these RSUs were granted on August 23, 2024. 100% of the RSUs granted vested on August 20, 2025, which was the earlier of the one year anniversary of the date of grant (August 23, 2025) and the date of the Issuer's 2025 Annual Meeting of Stockholders (which was held on August 20, 2025). Represents the grant of RSUs. 100% of the RSUs granted will vest on the earlier of the one year anniversary of the date of grant (August 20, 2026) and the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director of the Issuer on the applicable vesting date.
